GO:0016071 | mRNA metabolic process | 4.56e-08 | 6.57e-04 | 5.337 | 5 | 31 | 223 |
GO:0019083 | viral transcription | 6.35e-08 | 9.16e-04 | 6.476 | 4 | 10 | 81 |
GO:0016032 | viral process | 6.59e-08 | 9.50e-04 | 4.340 | 6 | 55 | 534 |
GO:0016070 | RNA metabolic process | 7.60e-08 | 1.10e-03 | 5.190 | 5 | 32 | 247 |
GO:0006415 | translational termination | 8.49e-08 | 1.22e-03 | 6.373 | 4 | 10 | 87 |
GO:0006414 | translational elongation | 1.11e-07 | 1.60e-03 | 6.277 | 4 | 13 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.75e-07 | 2.52e-03 | 6.116 | 4 | 10 | 104 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.53e-07 | 3.65e-03 | 5.983 | 4 | 11 | 114 |
GO:0019058 | viral life cycle | 2.62e-07 | 3.78e-03 | 5.971 | 4 | 13 | 115 |
GO:0006413 | translational initiation | 4.42e-07 | 6.38e-03 | 5.783 | 4 | 17 | 131 |
GO:0003735 | structural constituent of ribosome | 5.30e-07 | 7.64e-03 | 5.718 | 4 | 10 | 137 |
GO:0044267 | cellular protein metabolic process | 1.94e-06 | 2.79e-02 | 4.249 | 5 | 29 | 474 |
GO:0016020 | membrane | 2.08e-06 | 3.00e-02 | 2.908 | 7 | 90 | 1681 |
GO:0006412 | translation | 4.19e-06 | 6.05e-02 | 4.971 | 4 | 20 | 230 |
GO:0010467 | gene expression | 1.05e-05 | 1.52e-01 | 3.752 | 5 | 59 | 669 |
GO:0042273 | ribosomal large subunit biogenesis | 2.09e-05 | 3.02e-01 | 8.116 | 2 | 4 | 13 |
GO:0070062 | extracellular vesicular exosome | 2.40e-05 | 3.46e-01 | 2.395 | 7 | 104 | 2400 |
GO:0005829 | cytosol | 3.14e-05 | 4.52e-01 | 2.338 | 7 | 132 | 2496 |
GO:0019843 | rRNA binding | 9.38e-05 | 1.00e+00 | 7.061 | 2 | 3 | 27 |
GO:0044822 | poly(A) RNA binding | 9.68e-05 | 1.00e+00 | 3.094 | 5 | 49 | 1056 |
GO:0022627 | cytosolic small ribosomal subunit | 1.97e-04 | 1.00e+00 | 6.531 | 2 | 4 | 39 |
GO:0022625 | cytosolic large ribosomal subunit | 3.12e-04 | 1.00e+00 | 6.201 | 2 | 6 | 49 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0005515 | protein binding | 9.24e-04 | 1.00e+00 | 1.260 | 8 | 184 | 6024 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0006364 | rRNA processing | 1.15e-03 | 1.00e+00 | 5.261 | 2 | 6 | 94 |
GO:0006458 | 'de novo' protein folding | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0016602 | CCAAT-binding factor complex | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0043248 | proteasome assembly | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0046696 | lipopolysaccharide receptor complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0003688 | DNA replication origin binding | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 2 | 6 |
GO:0030957 | Tat protein binding | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 3 | 6 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0000028 | ribosomal small subunit assembly | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0070688 | MLL5-L complex | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0051604 | protein maturation | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0043032 | positive regulation of macrophage activation | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 10 |
GO:0032727 | positive regulation of interferon-alpha production | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 11 |
GO:0005838 | proteasome regulatory particle | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 7 | 12 |
GO:0001530 | lipopolysaccharide binding | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 3 | 13 |
GO:0051131 | chaperone-mediated protein complex assembly | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 4 | 14 |
GO:0042026 | protein refolding | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 2 | 15 |
GO:0050998 | nitric-oxide synthase binding | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 16 |
GO:0050870 | positive regulation of T cell activation | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 17 |
GO:0022624 | proteasome accessory complex | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 8 | 17 |
GO:0032733 | positive regulation of interleukin-10 production | 1.05e-02 | 1.00e+00 | 6.568 | 1 | 1 | 19 |
GO:0048863 | stem cell differentiation | 1.05e-02 | 1.00e+00 | 6.568 | 1 | 1 | 19 |
GO:0043234 | protein complex | 1.08e-02 | 1.00e+00 | 3.612 | 2 | 18 | 295 |
GO:0042100 | B cell proliferation | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 21 |
GO:0030863 | cortical cytoskeleton | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 4 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 4 | 23 |
GO:0043236 | laminin binding | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0042113 | B cell activation | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 2 | 25 |
GO:0032735 | positive regulation of interleukin-12 production | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 1 | 25 |
GO:0003723 | RNA binding | 1.43e-02 | 1.00e+00 | 3.398 | 2 | 20 | 342 |
GO:0043022 | ribosome binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 3 | 27 |
GO:0031492 | nucleosomal DNA binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 4 | 27 |
GO:0070491 | repressing transcription factor binding | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 28 |
GO:0019894 | kinesin binding | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 28 |
GO:0034504 | protein localization to nucleus | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 2 | 28 |
GO:0005925 | focal adhesion | 1.63e-02 | 1.00e+00 | 3.300 | 2 | 19 | 366 |
GO:0005654 | nucleoplasm | 1.77e-02 | 1.00e+00 | 2.322 | 3 | 76 | 1082 |
GO:0001895 | retina homeostasis | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 1 | 34 |
GO:0006605 | protein targeting | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 2 | 35 |
GO:0034332 | adherens junction organization | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 36 |
GO:0032755 | positive regulation of interleukin-6 production | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 4 | 37 |
GO:0070527 | platelet aggregation | 2.09e-02 | 1.00e+00 | 5.568 | 1 | 2 | 38 |
GO:0032729 | positive regulation of interferon-gamma production | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 2 | 39 |
GO:0043066 | negative regulation of apoptotic process | 2.15e-02 | 1.00e+00 | 3.088 | 2 | 31 | 424 |
GO:0042110 | T cell activation | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 3 | 42 |
GO:0021762 | substantia nigra development | 2.42e-02 | 1.00e+00 | 5.357 | 1 | 2 | 44 |
GO:0006521 | regulation of cellular amino acid metabolic process | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 17 | 50 |
GO:0006986 | response to unfolded protein | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 2 | 50 |
GO:0005905 | coated pit | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 3 | 50 |
GO:0003725 | double-stranded RNA binding | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 5 | 52 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 5 | 53 |
GO:0045216 | cell-cell junction organization | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 2 | 54 |
GO:0002039 | p53 binding | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 7 | 55 |
GO:0005840 | ribosome | 3.17e-02 | 1.00e+00 | 4.958 | 1 | 1 | 58 |
GO:0000502 | proteasome complex | 3.17e-02 | 1.00e+00 | 4.958 | 1 | 17 | 58 |
GO:0051087 | chaperone binding | 3.23e-02 | 1.00e+00 | 4.933 | 1 | 6 | 59 |
GO:0030141 | secretory granule | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 2 | 62 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.50e-02 | 1.00e+00 | 4.816 | 1 | 19 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 22 | 65 |
GO:0034329 | cell junction assembly | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 1 | 68 |
GO:0003697 | single-stranded DNA binding | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 5 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 22 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 20 | 72 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 6 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 22 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.09e-02 | 1.00e+00 | 4.587 | 1 | 20 | 75 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 7 | 77 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.30e-02 | 1.00e+00 | 4.512 | 1 | 23 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 3 | 80 |
GO:0050821 | protein stabilization | 4.78e-02 | 1.00e+00 | 4.357 | 1 | 2 | 88 |
GO:0006928 | cellular component movement | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 8 | 91 |
GO:0001649 | osteoblast differentiation | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 6 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 21 | 92 |
GO:0051082 | unfolded protein binding | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 5 | 93 |
GO:0014069 | postsynaptic density | 5.68e-02 | 1.00e+00 | 4.102 | 1 | 3 | 105 |
GO:0072562 | blood microparticle | 5.99e-02 | 1.00e+00 | 4.022 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 6.05e-02 | 1.00e+00 | 4.009 | 1 | 8 | 112 |
GO:0000209 | protein polyubiquitination | 6.26e-02 | 1.00e+00 | 3.958 | 1 | 20 | 116 |
GO:0006325 | chromatin organization | 6.36e-02 | 1.00e+00 | 3.933 | 1 | 5 | 118 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.78e-02 | 1.00e+00 | 3.839 | 1 | 5 | 126 |
GO:0000790 | nuclear chromatin | 6.94e-02 | 1.00e+00 | 3.805 | 1 | 9 | 129 |
GO:0044255 | cellular lipid metabolic process | 7.15e-02 | 1.00e+00 | 3.761 | 1 | 6 | 133 |
GO:0016887 | ATPase activity | 7.51e-02 | 1.00e+00 | 3.687 | 1 | 7 | 140 |
GO:0006457 | protein folding | 7.66e-02 | 1.00e+00 | 3.656 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 7.77e-02 | 1.00e+00 | 3.636 | 1 | 7 | 145 |
GO:0000082 | G1/S transition of mitotic cell cycle | 7.97e-02 | 1.00e+00 | 3.597 | 1 | 32 | 149 |
GO:0042981 | regulation of apoptotic process | 8.03e-02 | 1.00e+00 | 3.587 | 1 | 24 | 150 |
GO:0005769 | early endosome | 8.13e-02 | 1.00e+00 | 3.568 | 1 | 2 | 152 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 8.80e-02 | 1.00e+00 | 3.450 | 1 | 7 | 165 |
GO:0030424 | axon | 8.85e-02 | 1.00e+00 | 3.441 | 1 | 4 | 166 |
GO:0044212 | transcription regulatory region DNA binding | 8.95e-02 | 1.00e+00 | 3.424 | 1 | 6 | 168 |
GO:0034641 | cellular nitrogen compound metabolic process | 9.10e-02 | 1.00e+00 | 3.398 | 1 | 20 | 171 |
GO:0005615 | extracellular space | 9.43e-02 | 1.00e+00 | 1.914 | 2 | 17 | 957 |
GO:0032403 | protein complex binding | 9.71e-02 | 1.00e+00 | 3.300 | 1 | 10 | 183 |
GO:0005759 | mitochondrial matrix | 1.20e-01 | 1.00e+00 | 2.983 | 1 | 14 | 228 |
GO:0005737 | cytoplasm | 1.30e-01 | 1.00e+00 | 0.937 | 4 | 110 | 3767 |
GO:0043065 | positive regulation of apoptotic process | 1.39e-01 | 1.00e+00 | 2.750 | 1 | 10 | 268 |
GO:0044281 | small molecule metabolic process | 1.41e-01 | 1.00e+00 | 1.574 | 2 | 58 | 1211 |
GO:0005743 | mitochondrial inner membrane | 1.44e-01 | 1.00e+00 | 2.702 | 1 | 8 | 277 |
GO:0005856 | cytoskeleton | 1.50e-01 | 1.00e+00 | 2.631 | 1 | 12 | 291 |
GO:0006200 | ATP catabolic process | 1.51e-01 | 1.00e+00 | 2.626 | 1 | 15 | 292 |
GO:0005524 | ATP binding | 1.58e-01 | 1.00e+00 | 1.474 | 2 | 60 | 1298 |
GO:0019901 | protein kinase binding | 1.63e-01 | 1.00e+00 | 2.508 | 1 | 21 | 317 |
GO:0007411 | axon guidance | 1.64e-01 | 1.00e+00 | 2.499 | 1 | 13 | 319 |
GO:0043565 | sequence-specific DNA binding | 1.77e-01 | 1.00e+00 | 2.381 | 1 | 6 | 346 |
GO:0007155 | cell adhesion | 1.87e-01 | 1.00e+00 | 2.289 | 1 | 6 | 369 |
GO:0046982 | protein heterodimerization activity | 1.92e-01 | 1.00e+00 | 2.246 | 1 | 13 | 380 |
GO:0000278 | mitotic cell cycle | 1.97e-01 | 1.00e+00 | 2.205 | 1 | 48 | 391 |
GO:0009986 | cell surface | 2.02e-01 | 1.00e+00 | 2.165 | 1 | 11 | 402 |
GO:0007596 | blood coagulation | 2.26e-01 | 1.00e+00 | 1.986 | 1 | 18 | 455 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.36e-01 | 1.00e+00 | 1.915 | 1 | 13 | 478 |
GO:0006915 | apoptotic process | 2.69e-01 | 1.00e+00 | 1.700 | 1 | 33 | 555 |
GO:0045087 | innate immune response | 2.87e-01 | 1.00e+00 | 1.597 | 1 | 24 | 596 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.28e-01 | 1.00e+00 | 1.367 | 1 | 11 | 699 |
GO:0005886 | plasma membrane | 4.34e-01 | 1.00e+00 | 0.482 | 2 | 45 | 2582 |
GO:0006355 | regulation of transcription, DNA-templated | 4.36e-01 | 1.00e+00 | 0.855 | 1 | 18 | 997 |
GO:0005739 | mitochondrion | 4.37e-01 | 1.00e+00 | 0.853 | 1 | 28 | 998 |
GO:0005634 | nucleus | 4.89e-01 | 1.00e+00 | 0.247 | 3 | 136 | 4559 |
GO:0003677 | DNA binding | 5.06e-01 | 1.00e+00 | 0.566 | 1 | 28 | 1218 |
GO:0006351 | transcription, DNA-templated | 5.71e-01 | 1.00e+00 | 0.318 | 1 | 31 | 1446 |
GO:0005730 | nucleolus | 6.20e-01 | 1.00e+00 | 0.136 | 1 | 69 | 1641 |